Southern Cross Acquisition I Corp. has released its quarterly report for the third quarter of 2026, a crucial update for investors and stakeholders. The filing, dated November 17, 2026, provides insights into the company's financial health and operational strategies. As a blank check company, Southern Cross plays a significant role in facilitating mergers and acquisitions, making this update particularly relevant to the industry.
Company Background
Southern Cross Acquisition I Corp. operates under the Standard Industrial Classification (SIC) code 6770, which pertains to blank checks. The company is listed on the Nasdaq under the tickers NCO, NCOOR, NCOOU, and NCOOW. It is categorized as a non-accelerated filer, smaller reporting company, and an emerging growth company. The company is incorporated in New York and has a fiscal year ending on December 31.
What the Filing Says
In its latest 10-Q filing, Southern Cross reported that as of September 30, 2026, it held cash and cash equivalents valued at $801,362. This figure is critical as it indicates the company’s liquidity position and ability to pursue potential acquisition targets. The filing also noted that there were no redeemable shares outstanding, which could suggest a stable capital structure moving forward.
Impact
The financial data disclosed in the filing could impact various stakeholders, including investors, potential acquisition targets, and competitors in the blank check industry. Investors may view the company’s cash reserves as a positive sign, indicating readiness to engage in future deals. Additionally, competitors in the blank check space might feel pressure to enhance their offerings or adjust their strategies in response to Southern Cross's financial positioning.
What's Next
The filing does not specify what happens next for Southern Cross Acquisition I Corp. However, the company’s financial health and strategic direction will likely be closely monitored by investors and analysts as it seeks to capitalize on opportunities within the mergers and acquisitions landscape.
Source: SEC Filing Accession Number 0001929980-26-000605
Read Next
CannaPharmaRx Reports Zero Revenue in Q3 2026 Results
Quanome Technologies Reports Strong Q1 Results and AI Deal
AXE Compute Inc. Releases Third-Quarter Financial Results
Nutex Health declares special cash dividend of $2.00 per share
Sypris Solutions Reports Strong Q3 Results with 25% Revenue Growth
Griffon Corporation Reports Strong FY 2026 Results, Increases Buyback






